1 Study Coverage
    1.1 Typhoid Vi Polysaccharide Vaccine Product Introduction
    1.2 Market by Type
        1.2.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Child
        1.2.3 Adult
    1.3 Market by Application
        1.3.1 Global Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Government Institution
        1.3.3 Private Sector
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Typhoid Vi Polysaccharide Vaccine Sales Estimates and Forecasts 2017-2028
    2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Estimates and Forecasts 2017-2028
    2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Typhoid Vi Polysaccharide Vaccine Sales by Region
        2.4.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022)
        2.4.2 Global Sales Typhoid Vi Polysaccharide Vaccine by Region (2023-2028)
    2.5 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region
        2.5.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022)
        2.5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Manufacturers
        3.1.1 Global Top Typhoid Vi Polysaccharide Vaccine Manufacturers by Sales (2017-2022)
        3.1.2 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Typhoid Vi Polysaccharide Vaccine in 2021
    3.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturers
        3.2.1 Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturers (2017-2022)
        3.2.2 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Typhoid Vi Polysaccharide Vaccine Revenue in 2021
    3.3 Global Typhoid Vi Polysaccharide Vaccine Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Typhoid Vi Polysaccharide Vaccine Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Type
        4.1.1 Global Typhoid Vi Polysaccharide Vaccine Historical Sales by Type (2017-2022)
        4.1.2 Global Typhoid Vi Polysaccharide Vaccine Forecasted Sales by Type (2023-2028)
        4.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    4.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Type
        4.2.1 Global Typhoid Vi Polysaccharide Vaccine Historical Revenue by Type (2017-2022)
        4.2.2 Global Typhoid Vi Polysaccharide Vaccine Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    4.3 Global Typhoid Vi Polysaccharide Vaccine Price by Type
        4.3.1 Global Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2022)
        4.3.2 Global Typhoid Vi Polysaccharide Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Typhoid Vi Polysaccharide Vaccine Sales by Application
        5.1.1 Global Typhoid Vi Polysaccharide Vaccine Historical Sales by Application (2017-2022)
        5.1.2 Global Typhoid Vi Polysaccharide Vaccine Forecasted Sales by Application (2023-2028)
        5.1.3 Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    5.2 Global Typhoid Vi Polysaccharide Vaccine Revenue by Application
        5.2.1 Global Typhoid Vi Polysaccharide Vaccine Historical Revenue by Application (2017-2022)
        5.2.2 Global Typhoid Vi Polysaccharide Vaccine Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    5.3 Global Typhoid Vi Polysaccharide Vaccine Price by Application
        5.3.1 Global Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2022)
        5.3.2 Global Typhoid Vi Polysaccharide Vaccine Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Typhoid Vi Polysaccharide Vaccine Market Size by Type
        6.1.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
        6.1.2 North America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
    6.2 North America Typhoid Vi Polysaccharide Vaccine Market Size by Application
        6.2.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
        6.2.2 North America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
    6.3 North America Typhoid Vi Polysaccharide Vaccine Market Size by Country
        6.3.1 North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2028)
        6.3.2 North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
        6.3.3 the United States
        6.3.4 Canada
7 Europe
    7.1 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Type
        7.1.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
        7.1.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
    7.2 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Application
        7.2.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
        7.2.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
    7.3 Europe Typhoid Vi Polysaccharide Vaccine Market Size by Country
        7.3.1 Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2028)
        7.3.2 Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 UK
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Type
        8.1.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
        8.1.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
    8.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Application
        8.2.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
        8.2.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
    8.3 Asia Pacific Typhoid Vi Polysaccharide Vaccine Market Size by Region
        8.3.1 Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2028)
        8.3.2 Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Type
        9.1.1 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
        9.1.2 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
    9.2 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Application
        9.2.1 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
        9.2.2 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
    9.3 Latin America Typhoid Vi Polysaccharide Vaccine Market Size by Country
        9.3.1 Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2028)
        9.3.2 Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Type
        10.1.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2028)
    10.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Application
        10.2.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2028)
    10.3 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Market Size by Country
        10.3.1 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Sanofi Pasteur SA
        11.1.1 Sanofi Pasteur SA Corporation Information
        11.1.2 Sanofi Pasteur SA Overview
        11.1.3 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Sanofi Pasteur SA Recent Developments
    11.2 GSK
        11.2.1 GSK Corporation Information
        11.2.2 GSK Overview
        11.2.3 GSK Typhoid Vi Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 GSK Typhoid Vi Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Typhoid Vi Polysaccharide Vaccine Industry Chain Analysis
    12.2 Typhoid Vi Polysaccharide Vaccine Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Typhoid Vi Polysaccharide Vaccine Production Mode & Process
    12.4 Typhoid Vi Polysaccharide Vaccine Sales and Marketing
        12.4.1 Typhoid Vi Polysaccharide Vaccine Sales Channels
        12.4.2 Typhoid Vi Polysaccharide Vaccine Distributors
    12.5 Typhoid Vi Polysaccharide Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Typhoid Vi Polysaccharide Vaccine Industry Trends
    13.2 Typhoid Vi Polysaccharide Vaccine Market Drivers
    13.3 Typhoid Vi Polysaccharide Vaccine Market Challenges
    13.4 Typhoid Vi Polysaccharide Vaccine Market Restraints
14 Key Findings in The Global Typhoid Vi Polysaccharide Vaccine Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Child
    Table 3. Major Manufacturers of Adult
    Table 4. Global Typhoid Vi Polysaccharide Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
    Table 7. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Table 8. Global Typhoid Vi Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
    Table 9. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
    Table 10. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2017-2022)
    Table 12. Global Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region (2023-2028)
    Table 14. Global Typhoid Vi Polysaccharide Vaccine Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Manufacturers (2017-2022)
    Table 16. Global Typhoid Vi Polysaccharide Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Manufacturers (2017-2022)
    Table 18. Typhoid Vi Polysaccharide Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Typhoid Vi Polysaccharide Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Typhoid Vi Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Typhoid Vi Polysaccharide Vaccine as of 2021)
    Table 21. Typhoid Vi Polysaccharide Vaccine Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Typhoid Vi Polysaccharide Vaccine Product Offered
    Table 23. Date of Manufacturers Enter into Typhoid Vi Polysaccharide Vaccine Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 26. Global Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 27. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Type (2017-2022)
    Table 28. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Type (2023-2028)
    Table 29. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Type (2017-2022)
    Table 32. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Type (2023-2028)
    Table 33. Typhoid Vi Polysaccharide Vaccine Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Typhoid Vi Polysaccharide Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 36. Global Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 37. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Application (2017-2022)
    Table 38. Global Typhoid Vi Polysaccharide Vaccine Sales Share by Application (2023-2028)
    Table 39. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Application (2017-2022)
    Table 42. Global Typhoid Vi Polysaccharide Vaccine Revenue Share by Application (2023-2028)
    Table 43. Typhoid Vi Polysaccharide Vaccine Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Typhoid Vi Polysaccharide Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 46. North America Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 47. North America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 50. North America Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 51. North America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 54. North America Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
    Table 55. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Sanofi Pasteur SA Corporation Information
    Table 106. Sanofi Pasteur SA Description and Major Businesses
    Table 107. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Sanofi Pasteur SA Typhoid Vi Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Sanofi Pasteur SA Recent Developments
    Table 110. GSK Corporation Information
    Table 111. GSK Description and Major Businesses
    Table 112. GSK Typhoid Vi Polysaccharide Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. GSK Typhoid Vi Polysaccharide Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. GSK Recent Developments
    Table 115. Key Raw Materials Lists
    Table 116. Raw Materials Key Suppliers Lists
    Table 117. Typhoid Vi Polysaccharide Vaccine Distributors List
    Table 118. Typhoid Vi Polysaccharide Vaccine Customers List
    Table 119. Typhoid Vi Polysaccharide Vaccine Market Trends
    Table 120. Typhoid Vi Polysaccharide Vaccine Market Drivers
    Table 121. Typhoid Vi Polysaccharide Vaccine Market Challenges
    Table 122. Typhoid Vi Polysaccharide Vaccine Market Restraints
    Table 123. Research Programs/Design for This Report
    Table 124. Key Data Information from Secondary Sources
    Table 125. Key Data Information from Primary Sources
List of Figures
    Figure 1. Typhoid Vi Polysaccharide Vaccine Product Picture
    Figure 3. Global Typhoid Vi Polysaccharide Vaccine Market Share by Type in 2021 & 2028
    Figure 3. Child Product Picture
    Figure 4. Adult Product Picture
    Figure 5. Global Typhoid Vi Polysaccharide Vaccine Market Share by Application in 2021 & 2028
    Figure 6. Government Institution
    Figure 7. Private Sector
    Figure 8. Other
    Figure 9. Typhoid Vi Polysaccharide Vaccine Report Years Considered
    Figure 10. Global Typhoid Vi Polysaccharide Vaccine Sales 2017-2028 (K Units)
    Figure 11. Global Typhoid Vi Polysaccharide Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Typhoid Vi Polysaccharide Vaccine Revenue 2017-2028 (US$ Million)
    Figure 13. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2017-2022)
    Figure 15. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Region (2023-2028)
    Figure 16. North America Typhoid Vi Polysaccharide Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 17. North America Typhoid Vi Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Typhoid Vi Polysaccharide Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 19. Europe Typhoid Vi Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 21. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Typhoid Vi Polysaccharide Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 23. Latin America Typhoid Vi Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Sales YoY (2017-2028) & (K Units)
    Figure 25. Middle East & Africa Typhoid Vi Polysaccharide Vaccine Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Typhoid Vi Polysaccharide Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Typhoid Vi Polysaccharide Vaccine in the World: Market Share by Typhoid Vi Polysaccharide Vaccine Revenue in 2021
    Figure 28. Global Typhoid Vi Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 30. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 31. Global Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 32. Global Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 33. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 34. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 35. North America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 36. North America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 37. North America Typhoid Vi Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 38. North America Typhoid Vi Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 39. the United States Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 42. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 44. Europe Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Typhoid Vi Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 46. Europe Typhoid Vi Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 47. Germany Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 48. France Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 49. UK Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Typhoid Vi Polysaccharide Vaccine Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Typhoid Vi Polysaccharide Vaccine Revenue Share by Region (2017-2028)
    Figure 58. China Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 61. India Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Typhoid Vi Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 72. Latin America Typhoid Vi Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 73. Mexico Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Typhoid Vi Polysaccharide Vaccine Revenue Share by Country (2017-2028)
    Figure 82. Turkey Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Typhoid Vi Polysaccharide Vaccine Revenue (2017-2028) & (US$ Million)
    Figure 85. Typhoid Vi Polysaccharide Vaccine Value Chain
    Figure 86. Typhoid Vi Polysaccharide Vaccine Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed